J.‐R. Bertrand

638 total citations
20 papers, 522 citations indexed

About

J.‐R. Bertrand is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, J.‐R. Bertrand has authored 20 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Organic Chemistry. Recurrent topics in J.‐R. Bertrand's work include DNA and Nucleic Acid Chemistry (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). J.‐R. Bertrand is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). J.‐R. Bertrand collaborates with scholars based in France, Russia and Hungary. J.‐R. Bertrand's co-authors include Claude Malvy, Patrick Couvreur, Paule Opolon, J. P. Vannier, Julia Varet, Claudine Soria, Lu H, J. Soria, Grégory Lambert and Elias Fattal and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

J.‐R. Bertrand

20 papers receiving 506 citations

Peers

Countries citing papers authored by J.‐R. Bertrand

Since Specialization

Citations

This map shows the geographic impact of J.‐R. Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐R. Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐R. Bertrand more than expected).

Fields of papers citing papers by J.‐R. Bertrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐R. Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐R. Bertrand. The network helps show where J.‐R. Bertrand may publish in the future.

Co-authorship network of co-authors of J.‐R. Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐R. Bertrand. A scholar is included among the top collaborators of J.‐R. Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐R. Bertrand. J.‐R. Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	siRNA associated with immunonanoparticles directed against cd99 antigen improves gene expression inhibition in vivo in Ewing's sarcoma 2013 ·Journal of Molecular Recognition ·(unknown), J.‐R. Bertrand, (unknown), Ghislaine Bernard, Gilles Ponchel, Claude Malvy, Christine Vauthier	14
2	siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma 2007 ·Nucleic Acids Research ·(unknown), J.‐R. Bertrand, Alfredo Fusco, Massimo Santoro, Patrick Couvreur, Christine Vauthier, Claude Malvy	45
3	Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in Vivo 2004 ·Molecular Therapy ·(unknown), (unknown), Julia Varet, J.‐R. Bertrand, J. Soria, Paule Opolon, Lu H, (unknown), J. P. Vannier, Claude Malvy, Claudine Soria, (unknown)	218
4	Covalent Coupling of a PIM-1 Oncogene Targeted PNA with an Antennapedia Derived Peptide 2003 ·Nucleosides Nucleotides & Nucleic Acids ·J.‐R. Bertrand, Natalia V. Sumbatyan, Claude Malvy	3
5	Therapeutic Potentialities of EWS‐Fli‐1 mRNA‐Targeted Vectorized Antisense Oligonucleotides 2003 ·Annals of the New York Academy of Sciences ·Andrei Maksimenko, Grégory Lambert, J.‐R. Bertrand, Elias Fattal, Patrick Couvreur, Claude Malvy	30
6	Interaction of fusogenic peptides with an antisense oligonucleotide in solution and in the presence of micelles: conformational studies 2003 ·Biochemical and Biophysical Research Communications ·Ilona Laczkó, Sándor Bottka, Gábor K. Tóth, Claude Malvy, J.‐R. Bertrand, M. Hollósi	4
7	A two step model aimed at delivering antisense oligonucleotides in targeted cells 2002 ·Biochemical and Biophysical Research Communications ·Judit Tóth, (unknown), (unknown), Ilona Laczkó, Claude Malvy, M. Hollósi, J.‐R. Bertrand	9
8	Modified alkaline elution allows the measurement ofintact apurinic sites in mammalian genomic DNA 2000 ·Biochimie ·Claude Malvy, (unknown), J.‐R. Bertrand, Judith Markovits	2
9	EWS Fli-1 Antisense Nanocapsules Inhibits Ewing Sarcoma-Related Tumor in Mice 2000 ·Biochemical and Biophysical Research Communications ·Grégory Lambert, J.‐R. Bertrand, Elias Fattal, Frédéric Subra, Huguette Pinto‐Alphandary, Claude Malvy, Christian Auclair, Patrick Couvreur	95
10	α−β Chimeric Oligonucleotides Form a New Stable “Snail-like” Structure 1996 ·Journal of the American Chemical Society ·Marina Gottikh, Оlga А. Fedorova, (unknown), Sylviane Giorgi‐Renault, J.‐R. Bertrand, З.А. Шабарова, Claude Malvy	5
11	αβ Chimeric Antisense Oligonucleotides: Synthesis and Nuclease Resistance in Biological Media 1994 ·PubMed ·Marina Gottikh, J.‐R. Bertrand, (unknown), Elie Lescot, Sylviane Giorgi‐Renault, З.А. Шабарова, Claude Malvy	8
12	Ethmoid sinus carcinomas: Results and prognosis after neoadjuvant chemotherapy and combined surgery—A 10-Year experience 1994 ·Surgical Neurology ·François‐Xavier Roux, Daniel Brasnu, Bertrand Devaux, (unknown), G Schwaab, O. Laccourreye, M. Ménard, François Janot, Suzanne Nguyen, J.‐R. Bertrand, J. Meder	31
13	Molecular Modelling of 9-Aminoellipticine Interactions with Abasic Oligonucleotides 1991 ·Journal of Biomolecular Structure and Dynamics ·R. Letellier, (unknown), J.‐R. Bertrand, Claude Malvy	6
14	Mechanism of Cleavage of Apurinic Sites by 9-Aminoellipticine 1989 ·Journal of Biological Chemistry ·J.‐R. Bertrand, Jean‐Jacques Vasseur, Alain Gouyette, Bernard Rayner, Jean‐Louis Imbach, Claude Paoletti, Claude Malvy	18
15	Involvement of apurinic sites in the synergistic action of alkylating and intercalating drugs in Escherichia coli. 1988 ·PubMed ·Claude Malvy, (unknown), (unknown), J.‐R. Bertrand	10
16	Differential reactivity of 9‐NH₂‐ellipticine on apurinic and apyrimidinic sites in circular DNA 1986 ·FEBS Letters ·Claude Malvy, J.‐R. Bertrand	3
17	Ellipticines: correlation between in vitro DNA intercalation and physiological properties? 1985 ·PubMed ·J.‐R. Bertrand, Paolo U. Giacomoni	2
18	Désamination de l'hydroxylsine par la L-aminoacide-deshydrogénase du foie de dindon (meleagris gallopavo l) 1958 ·Biochimica et Biophysica Acta ·P Boulanger, (unknown), J.‐R. Bertrand	1
19	[Deamination of ornithine and lysine selectively labeled by heavy nitrogen by L-amino acid dehydrogenase from the liver of the turkey cock]. 1957 ·PubMed ·P Boulanger, (unknown), J.‐R. Bertrand, (unknown)	1
20	Désamination de l'ornithine et de la lysine sélectivement marquées par la L-aminoacide-déshydrogénase du foie de dindon (Meleagris gallopavo L) 1957 ·Biochimica et Biophysica Acta ·P Boulanger, J.‐R. Bertrand, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact